Nordea Investment Management AB Acquires 142,451 Shares of DENTSPLY SIRONA Inc. $XRAY

Nordea Investment Management AB increased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 33.3% in the third quarter, Holdings Channel.com reports. The fund owned 570,466 shares of the medical instruments supplier’s stock after buying an additional 142,451 shares during the quarter. Nordea Investment Management AB’s holdings in DENTSPLY SIRONA were worth $7,194,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of XRAY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in DENTSPLY SIRONA in the 1st quarter valued at $26,000. Trust Co. of Toledo NA OH purchased a new stake in shares of DENTSPLY SIRONA during the second quarter valued at $27,000. Parkside Financial Bank & Trust grew its holdings in shares of DENTSPLY SIRONA by 620.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,477 shares during the last quarter. True Wealth Design LLC grew its holdings in shares of DENTSPLY SIRONA by 273.0% in the second quarter. True Wealth Design LLC now owns 2,376 shares of the medical instruments supplier’s stock worth $38,000 after purchasing an additional 1,739 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its stake in DENTSPLY SIRONA by 160.2% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 2,805 shares of the medical instruments supplier’s stock worth $45,000 after buying an additional 1,727 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier sold 82,200 shares of the stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.50% of the stock is currently owned by company insiders.

DENTSPLY SIRONA Trading Down 2.9%

Shares of NASDAQ:XRAY opened at $12.21 on Friday. The company has a market capitalization of $2.44 billion, a PE ratio of -2.76, a P/E/G ratio of 0.97 and a beta of 1.00. The company has a current ratio of 1.47, a quick ratio of 0.99 and a debt-to-equity ratio of 1.36. DENTSPLY SIRONA Inc. has a 12-month low of $9.85 and a 12-month high of $20.59. The business’s fifty day simple moving average is $11.35 and its 200-day simple moving average is $13.05.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.The company had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.33 million. During the same quarter last year, the company earned $0.50 earnings per share. The company’s revenue for the quarter was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. As a group, equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were given a $0.16 dividend. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 5.2%. DENTSPLY SIRONA’s payout ratio is presently -14.48%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on XRAY. Barclays began coverage on shares of DENTSPLY SIRONA in a research report on Monday, December 8th. They issued an “underweight” rating and a $12.00 price objective for the company. Barrington Research reissued an “outperform” rating and issued a $14.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, January 5th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Wall Street Zen cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, October 18th. Finally, UBS Group dropped their price target on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a research report on Tuesday, October 28th. Two equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and an average price target of $15.15.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.